tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Candel Therapeutics appoints Pulendran to Candel’s RAB
PremiumThe FlyCandel Therapeutics appoints Pulendran to Candel’s RAB
27d ago
Candel Therapeutics: Hold Rating Amid Promising Developments and Financial Uncertainty
Premium
Ratings
Candel Therapeutics: Hold Rating Amid Promising Developments and Financial Uncertainty
28d ago
Candel Therapeutics Secures $130M Loan for Trials
Premium
Company Announcements
Candel Therapeutics Secures $130M Loan for Trials
29d ago
Promising Potential of Candel Therapeutics’ CAN-2409: A Versatile Immunotherapy with Broad Applicability
PremiumRatingsPromising Potential of Candel Therapeutics’ CAN-2409: A Versatile Immunotherapy with Broad Applicability
1M ago
Candel Therapeutics presents Phase 3 clinical trial of CAN-2409
Premium
The Fly
Candel Therapeutics presents Phase 3 clinical trial of CAN-2409
1M ago
Candel Therapeutics downgraded to Neutral at BofA on lack of catalysts
Premium
The Fly
Candel Therapeutics downgraded to Neutral at BofA on lack of catalysts
2M ago
Candel Therapeutics Faces Uncertainty Despite FDA RMAT Designation for Prostate Cancer Treatment
PremiumCompany AnnouncementsCandel Therapeutics Faces Uncertainty Despite FDA RMAT Designation for Prostate Cancer Treatment
3M ago
Candel Therapeutics’ CAN-2409: Promising Phase 3 Results and Market Potential
Premium
Ratings
Candel Therapeutics’ CAN-2409: Promising Phase 3 Results and Market Potential
3M ago
Candel Therapeutics: Promising Pipeline Developments and Strategic Advancements Support Buy Rating
Premium
Ratings
Candel Therapeutics: Promising Pipeline Developments and Strategic Advancements Support Buy Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100